Saving changes...

Done

Error

How Translational Research is shifting the Treatment Paradigm from Symptom Management to Cure

How Translational Research is shifting the Treatment Paradigm from Symptom Management to Cure

How Translational Research is shifting the Treatment Paradigm from Symptom Management to Cure

Rosa Bacchetta (MD), Nicholas W. Lukacs (PhD), Natalija Novak (MD), Jennifer M. Puck (MD), and Rudol
Rosa Bacchetta (MD), Nicholas W. Lukacs (PhD), Natalija Novak (MD), Jennifer M. Puck (MD), and Rudol
on behalf of American Academy of Allergy Asthma & Immunology

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 $ 15.00 $ 15.00
$ 15.00 $ 15.00 $ 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 27 Jun 2018
Expiry Date:

Last updated: 22 Aug 2018

Reference: 190424

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

The major goal of the course is to present translational research to be understood by a broader audience.

Objectives

Discuss how genetic factors and the environment interact to determine allergic sensitization
Upon completion of this session, participants should be able to discuss how genetic factors and the environment interact to determine allergic sensitization.
Identify potential targets for prevention and treatment
Upon completion of this session, participants should be able to identify potential targets for prevention and treatment.
Discuss different types of treatment for allergic diseases
Upon completion of this session, participants should be able to discuss different types of treatment for allergic diseases.
Rosa Bacchetta (MD), Nicholas W. Lukacs (PhD), Natalija Novak (MD), Jennifer M. Puck (MD), and Rudol

Author Information Play Video Bio

Rosa Bacchetta (MD), Nicholas W. Lukacs (PhD), Natalija Novak (MD), Jennifer M. Puck (MD), and Rudol
on behalf of American Academy of Allergy Asthma & Immunology

Rosa Bacchetta, MD, Stanford School of Medicine, Stanford, CA

Nicholas W. Lukacs, PhD, University of Michigan, Ann Arbor, MI

Natalija Novak, MD, University of Bonn, Bonn, Germany

Jennifer M. Puck, MD, University of California, San Francisco, CA

Rudolf Valenta, MD, Medical University of Vienna AKH, Wien, Austria

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 2.50 Credits
  • California Board of Registered Nursing (CBRN)
  • 2.50 Hours

Faculty and Disclosures

Rosa Bacchetta, MD

Rosa Bacchetta, MD

No Conflict
Nicholas W. Lukacs, PhD

Nicholas W. Lukacs, PhD

No Conflict
Natalija Novak, MD

Natalija Novak, MD

Potential Conflict

Alk Abello (Ongoing): Speaker/Clinical
Studies
Bencard Allergy Therapeutics:
Speaker/Clinical Studies
Leti Pharma (Ongoing): Clinical
Studies/Consultancy
Novartis (Ongoing): Speaker/Clinical
Studies
Jennifer M. Puck, MD

Jennifer M. Puck, MD

Potential Conflict

Consultant: Husband: consultant for
Complete Genomics, Inc
Honorarium/Gift: Baxter/Baxalta Global
Immunodeficiency Leadership Expert
Advisory Panel
Rudolf Valenta, MD

Rudolf Valenta, MD

Potential Conflict

Consultant: Biomay AG Vienna, Austria
Consultant: Thermofisher, Uppsala,
Sweden
Consultant: Fresenius Medical Care, Bad
Homburg, Germany
Thermofisher Uppsala (Ongoing): Research
Grant
Austrian Science Fund FWF (Ongoing):
Research grant
Biomay Vienna (Ongoing): Research Grant
Fresenius Medical Care (Ongoing):
Research Grant

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error